The Scientist

» pharma and ecology

Most Recent

image: Roche Set to Buy RNAi Firm

Roche Set to Buy RNAi Firm

By | August 6, 2014

The Swiss pharmaceutical giant will reportedly pay $450 million for a Danish biotech company that develops drugs that silence microRNAs.

2 Comments

image: Meal Plans

Meal Plans

By | August 1, 2014

Bacterial populations’ differing strategies for responding to their environment can set genetic routes to speciation.

1 Comment

image: Super Sniffers?

Super Sniffers?

By | July 24, 2014

African elephants have more genes for olfactory receptors than dogs or humans, a study shows. 

1 Comment

image: Dustup Over Lionfish Science Fair Project

Dustup Over Lionfish Science Fair Project

By | July 23, 2014

A former graduate student says he feels slighted by a failure to attribute his contributions to a line of research regarding the salinity tolerances of an invasive species.

15 Comments

image: Insecticides Harm Birds Indirectly

Insecticides Harm Birds Indirectly

By | July 10, 2014

The effects of neonicotinoid use on insect populations appear to be rippling through the food chain, scientists show.

1 Comment

image: Lichen Legion

Lichen Legion

By | July 2, 2014

Genetic analysis splits one species into 126.

0 Comments

image: Emperor Penguins on Thin Ice

Emperor Penguins on Thin Ice

By | June 30, 2014

A new model suggests emperor penguin populations could decline by 19 percent by 2100.

0 Comments

image: Mosquitoes Attracted to Malaria-Infected Mice

Mosquitoes Attracted to Malaria-Infected Mice

By | June 30, 2014

Mice infected with a malaria-causing parasite emit odors that are more attractive to malaria-transmitting mosquitoes than uninfected animals, a study shows.

2 Comments

image: EMA Gearing Up for Transparency

EMA Gearing Up for Transparency

By | June 16, 2014

The European Medicines Agency is preparing for a new policy that will release rarely-seen clinical trial reports for independent scrutiny.  

0 Comments

image: Merck Snaps Up Biotech for $3.85B

Merck Snaps Up Biotech for $3.85B

By | June 10, 2014

The drug giant will acquire Cambridge, Massachusetts-based Idenix Pharmaceuticals, which is focused on developing treatments for hepatitis C.

0 Comments

Popular Now

  1. Top 10 Innovations 2016
    Features Top 10 Innovations 2016

    This year’s list of winners celebrates both large leaps and small (but important) steps in life science technology.

  2. Gut Microbes Linked to Neurodegenerative Disease
  3. Pubic Hair Grooming Linked to STI Risk
    The Nutshell Pubic Hair Grooming Linked to STI Risk

    Observational study suggests pubic hair grooming correlates with heightened risk of acquiring sexually transmitted infections, although causation remains unclear.

  4. Image of the Day: Parting Ways
    Image of the Day Image of the Day: Parting Ways

    The Allen Institute for Cell Science releases the first public collection of human induced pluripotent stem cells that have been fluorescently tagged using CRISPR.

Rockland